- Report
- August 2025
- 181 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- October 2025
- 195 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- September 2025
- 250 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- January 2025
- 175 Pages
Global
From €4017EUR$4,490USD£3,532GBP
- Report
- August 2025
- 189 Pages
Global
From €3171EUR$3,545USD£2,788GBP
€3524EUR$3,939USD£3,098GBP
- Report
- February 2025
- 150 Pages
Global
From €3444EUR$3,850USD£3,028GBP
€4339EUR$4,850USD£3,815GBP
- Report
- August 2022
- 120 Pages
Global
From €4026EUR$4,500USD£3,539GBP
- Report
- November 2018
- 30 Pages
China
From €1968EUR$2,200USD£1,730GBP
- Report
- November 2025
- 50 Pages
Global
From €2371EUR$2,650USD£2,084GBP
Perindopril is a drug used to treat cardiovascular diseases, such as hypertension, coronary artery disease, and heart failure. It belongs to a class of drugs known as angiotensin-converting enzyme (ACE) inhibitors, which work by blocking the action of a hormone that causes blood vessels to narrow. Perindopril is usually taken once a day, and it can be used in combination with other medications to treat more severe cases of cardiovascular disease. It is generally well-tolerated, with few side effects.
Perindopril is available in both generic and brand-name formulations. Some of the major companies that produce perindopril include Pfizer, Merck, Novartis, and Sanofi. Generic versions of the drug are also available from a variety of manufacturers. Show Less Read more